News Quantified

GRTX – galera therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Galera Adopts Limited Duration Stockholder Rights Agreement [Yahoo! Finance]

Galera Adopts Limited Duration Stockholder Rights Agreement

Carisma Therapeutics names Eugene Kennedy as chief medical officer May 02, 2024 8:02 AM ET By: Sinchita Mitra , SA News Editor [Seeking Alpha]

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates [Yahoo! Finance]

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

Form 8-K Galera Therapeutics, For: May 02

Form 8-A12B Galera Therapeutics,

Form 4/A Galera Therapeutics, For: Apr 17 Filed by: Schneid Yair

Form SC 13G/A Galera Therapeutics, Filed by: Schneid Yair

Form SC 13G Galera Therapeutics, Filed by: ALPHA PHARMA Investments LLC

Top News Gainers

12/17 Form 4 Galera Therapeutics, For: Dec 13 Filed by: Alleva Lawrence M 16.2%

11/15 Form SC 13G Galera Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C. 8.2%

2/27 Galera Therapeutics Announces Avasopasem Manganese (GC4419) Maintained Anti-Cancer Benefit of Chemoradiotherapy for Head and Neck Cancer While Substantially Reducing Radiation-Induced Severe Oral Mucositis 7.1%

2/19 Galera Therapeutics to Present at Cowen and Company 40th Annual Health Care Conference 7.0%

4/23 Galera Therapeutics (NASDAQ: GRTX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.1%

4/16 Galera Therapeutics (NASDAQ: GRTX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock. 5.0%

3/19 Galera Therapeutics (GRTX) Investor Presentation - Slideshow [Seeking Alpha] 4.5%

4/17 Galera Therapeutics (NASDAQ: GRTX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.4%

11/14 Form 4 Galera Therapeutics, For: Nov 12 Filed by: Novo Holdings A/S 3.3%

2/4 Form 4 Galera Therapeutics, For: Jan 31 Filed by: Beardsley Robert A 2.1%

Top News Decliners

4/30 Galera Therapeutics Announces Presentation of Avasopasem Manganese Data at ASCO 2020 Virtual Scientific Program -9.6%

11/14 Form 4 Galera Therapeutics, For: Nov 12 Filed by: Clarus IV-D, L.P. -9.3%

2/24 Galera Therapeutics Announces Presentation of Avasopasem Manganese (GC4419) Two-Year Tumor Outcomes Data at 2020 Multidisciplinary Head and Neck Cancers Symposium -7.4%

12/2 Galera Therapeutics (NASDAQ: GRTX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $30.00 price target on the stock. -6.0%

4/30 Galera Therapeutics (NASDAQ: GRTX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock. -5.2%

4/22 Galera Therapeutics (NASDAQ: GRTX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock. -5.1%

12/10 Form 10-Q Galera Therapeutics, For: Sep 30 -5.0%

11/6 Galera Therapeutics Announces Pricing of Initial Public Offering -4.0%

1/7 Galera Therapeutics Announces Dosing of First Patient in Phase 2a Clinical Trial of Avasopasem Manganese (GC4419) in Second Indication -3.5%

3/10 Q4/2019 12/31/2019 EPS -1.310 ZacksConsensus N/A ActVsEst N/A - N/A -2.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day